Both in R&D — Physical & Biological Sciences
Absci vs IB Acquisition
Over the past year ABSI returned +143.3% and IBAC returned +3.6%; their daily moves had a correlation of 0.04.
ABSI +143.3% IBAC +3.6%Growth of $1, one year, split-adjusted
| Metric | ABSI | IBAC |
|---|---|---|
| Price | $10.00 | $10.81 |
| Market cap | $1.72B | $54.1M |
| Today | −10.15% | −0.46% |
| 1 month | −9.7% | −0.9% |
| 6 months | +77.9% | −0.1% |
| Year to date | +186.5% | +3.0% |
| 1 year | +144.5% | — |
| Revenue growth (YoY) | −46.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −10443.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 1,099.4× | — |
| Net cash | $201.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 98.8% | 20.1% |
| Short % of float | 31.0% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).